NCT04896489

Brief Summary

The purpose of this study is to determine whether hydrocortisone biases formation of alcohol-related memories to potentiate drinking.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at P25-P50 for early_phase_1

Timeline
Completed

Started May 2021

Shorter than P25 for early_phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 12, 2021

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

May 17, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 21, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2022

Completed
Last Updated

June 2, 2022

Status Verified

June 1, 2022

Enrollment Period

10 months

First QC Date

May 17, 2021

Last Update Submit

June 1, 2022

Conditions

Outcome Measures

Primary Outcomes (4)

  • Changes fMRI signal

    Changes in fMRI signal at encoding will be assessed over an hour long period.

    1 hour

  • Item memory

    Item memory will be assessed through performance on delayed memory assessments. Item memory is determined by the accuracy of memory for individual items and will be expressed as dprime.

    Up to 90 minutes

  • Context memory

    Context memory will be assessed through performance on delayed memory assessments. Context memory is determined by the accuracy of memory for associated contexts and will be expressed as % correct.

    Up to 90 minutes

  • Affect memory

    Affect memory will be assessed through performance on delayed memory assessments. Affect memory is determined by subjective ratings of vividness (1-4), change in ratings from encoding to retrieval of memory (0-3). The score is averaged where a higher score indicates greater affect.

    Up to 90 minutes

Secondary Outcomes (4)

  • Alcohol motivation

    10 minutes

  • Affect - Negative

    10 minutes

  • Affect - Positive

    10 minutes

  • Neuroendocrine/cortisol reactivity

    Baseline to 2 hours

Study Arms (2)

hydrocortisone

EXPERIMENTAL

Participants receive hydrocortisone (20mg)

Drug: Hydrocortisone 20 MG

placebo

PLACEBO COMPARATOR

Participants receive placebo.

Other: Placebo

Interventions

Participants receive Hydrocortisone 20 MG

hydrocortisone
PlaceboOTHER

Participants receive placebo

placebo

Eligibility Criteria

Age21 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Able to read and write English
  • BMI 18-35
  • Beer drinking

You may not qualify if:

  • Meet current criteria for any substance use disorder, excluding caffeine
  • Current significant medical conditions or psychiatric symptoms requiring medication
  • Current use of medications/drugs that interfere with the HPA axis response
  • Peri and post-menopausal women, pregnant or lactating women, and those with hysterectomies
  • Metal in body (for MRI safety)
  • Systemic fungal infections (contraindication for hydrocortisone)
  • Known hypersensitivity to components of hydrocortisone tablets (hydrocortisone, calcium stearate, corn starch, lactose, mineral oil, sorbic acid, sucrose)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yale University

New Haven, Connecticut, 06511, United States

Location

MeSH Terms

Conditions

Alcohol DrinkingDrinking Behavior

Interventions

Hydrocortisone

Condition Hierarchy (Ancestors)

Behavior

Intervention Hierarchy (Ancestors)

PregnenedionesPregnenesPregnanesSteroidsFused-Ring CompoundsPolycyclic Compounds11-HydroxycorticosteroidsHydroxycorticosteroidsAdrenal Cortex HormonesHormonesHormones, Hormone Substitutes, and Hormone Antagonists17-Hydroxycorticosteroids

Study Officials

  • Elizabeth V Goldfarb, PhD

    Yale University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 17, 2021

First Posted

May 21, 2021

Study Start

May 12, 2021

Primary Completion

March 15, 2022

Study Completion

March 15, 2022

Last Updated

June 2, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will share

Individual participant data that underlie the results reported in published articles will be shared after de-identification.

Shared Documents
STUDY PROTOCOL
Time Frame
Immediately following publication with no end date.
Access Criteria
Anyone who wishes to have access to the data may do so.

Locations